Effect of 3-aminobenzamide on antigenic variation of Trypanosoma brucei
African trypanosomes, like Trypanosoma brucei, depend on antigenic variation to evade the immune response of the vertebrate host. An antigenic switch corresponds to the activation of a variable surface glycoprotein (VSG) gene from a large silent repertoire. Most switches require the duplicative tran...
Saved in:
Published in | Biochemical pharmacology Vol. 34; no. 23; p. 4151 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.12.1985
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | African trypanosomes, like Trypanosoma brucei, depend on antigenic variation to evade the immune response of the vertebrate host. An antigenic switch corresponds to the activation of a variable surface glycoprotein (VSG) gene from a large silent repertoire. Most switches require the duplicative transposition of a VSG gene, which involves strand breaks in DNA and subsequent repair. The nuclear enzyme adenosine-diphosphoribosyl transferase (ADPRT), which is dependent on the presence of DNA strand breaks for its activity, might be involved in this process because it has a regulatory role in DNA repair in all eukaryotic cells studied so far. In previous work, the presence of ADPRT activity was demonstrated in T. brucei. Moreover, it was also shown in isolated trypanosomes the ADPRT activity, which is stimulated by the induction of DNA strand breaks, could be blocked by the competitive inhibitor 3-aminobenzamide. Here we report experiments using rats which were infected with small numbers of T. brucei expressing VSG gene 118. After two days, the rats were coupled to a continuous intraperitoneal infusion system administrating 3-aminobenzamide in 0.9% NaCl (81.4 mM) at a rate of 0.65 ml/hr/rat for a period of up to five days. Control rats received only a 0.9% NaCl infusion. At days 1, 3 and 5, 250 microliters blood was obtained from a tail artery. Plasma 3-aminobenzamide was determined using a new high performance liquid chromatography method, developed for these experiments. In most rats the plasma concentrations were maintained between 0.8 and 1.2 mM. The rate of antigenic switching was determined by quantitating the fraction of trypanosomes that had lost their VSG 118 coat, using antibody against VSG 118 and a limiting dilution in mice. The average switching rate found was 2.0 X 10(-6) in controls and 1.3 X 10(-7) in drug-treated rats (15-fold reduction). This suggests that ADPRT is required for completing most antigenic switching events. We discuss the possibility that drug-resistant switching only involves non-duplicative VSG gene activation. |
---|---|
AbstractList | African trypanosomes, like Trypanosoma brucei, depend on antigenic variation to evade the immune response of the vertebrate host. An antigenic switch corresponds to the activation of a variable surface glycoprotein (VSG) gene from a large silent repertoire. Most switches require the duplicative transposition of a VSG gene, which involves strand breaks in DNA and subsequent repair. The nuclear enzyme adenosine-diphosphoribosyl transferase (ADPRT), which is dependent on the presence of DNA strand breaks for its activity, might be involved in this process because it has a regulatory role in DNA repair in all eukaryotic cells studied so far. In previous work, the presence of ADPRT activity was demonstrated in T. brucei. Moreover, it was also shown in isolated trypanosomes the ADPRT activity, which is stimulated by the induction of DNA strand breaks, could be blocked by the competitive inhibitor 3-aminobenzamide. Here we report experiments using rats which were infected with small numbers of T. brucei expressing VSG gene 118. After two days, the rats were coupled to a continuous intraperitoneal infusion system administrating 3-aminobenzamide in 0.9% NaCl (81.4 mM) at a rate of 0.65 ml/hr/rat for a period of up to five days. Control rats received only a 0.9% NaCl infusion. At days 1, 3 and 5, 250 microliters blood was obtained from a tail artery. Plasma 3-aminobenzamide was determined using a new high performance liquid chromatography method, developed for these experiments. In most rats the plasma concentrations were maintained between 0.8 and 1.2 mM. The rate of antigenic switching was determined by quantitating the fraction of trypanosomes that had lost their VSG 118 coat, using antibody against VSG 118 and a limiting dilution in mice. The average switching rate found was 2.0 X 10(-6) in controls and 1.3 X 10(-7) in drug-treated rats (15-fold reduction). This suggests that ADPRT is required for completing most antigenic switching events. We discuss the possibility that drug-resistant switching only involves non-duplicative VSG gene activation. |
Author | Shall, S Michels, P A Versluijs-Broers, J A Van der Meer, C Spanjer, W Borst, P Farzaneh, F Cornelissen, A W |
Author_xml | – sequence: 1 givenname: A W surname: Cornelissen fullname: Cornelissen, A W – sequence: 2 givenname: P A surname: Michels fullname: Michels, P A – sequence: 3 givenname: P surname: Borst fullname: Borst, P – sequence: 4 givenname: W surname: Spanjer fullname: Spanjer, W – sequence: 5 givenname: J A surname: Versluijs-Broers fullname: Versluijs-Broers, J A – sequence: 6 givenname: C surname: Van der Meer fullname: Van der Meer, C – sequence: 7 givenname: F surname: Farzaneh fullname: Farzaneh, F – sequence: 8 givenname: S surname: Shall fullname: Shall, S |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/2998400$$D View this record in MEDLINE/PubMed |
BookMark | eNo9j09LAzEUxHOo1Lb6DRT2qIfoS_ZP3h6ltFUoeKnn8pJ9kYiblN2tUD-9KxZPM_NjGJi5mMQUWYgbBQ8KVPUIAJXUdanvsLyvQQPKYiJm__hSzPv-4zdipaZiqusaC4CZ2Ky8ZzdkyWe5pDbEZDl-j6bhLMWM4hDeOQaXfVEXaAgjG6u77nSgmPrUUma7o-NwJS48ffZ8fdaFeFuvdstnuX3dvCyfttIVygxS2xINKmvQWfBsiZ2vckWMqjCE2FgD5JVWJebOEGlfeK5yaIhrUwLqhbj92z0cbcvN_tCFlrrT_nxI_wC95k4Z |
CitedBy_id | crossref_primary_10_1016_0014_4827_87_90385_5 crossref_primary_10_1016_0163_7258_85_90026_9 crossref_primary_10_1016_j_actatropica_2020_105499 crossref_primary_10_1016_0022_2836_87_90717_0 crossref_primary_10_1016_0014_4894_88_90090_2 crossref_primary_10_1016_0305_0491_90_90051_T crossref_primary_10_1016_0378_1119_92_90557_6 crossref_primary_10_1080_09553008714551431 crossref_primary_10_1016_0006_2952_87_90065_7 crossref_primary_10_1016_0167_8140_89_90083_2 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1016/0006-2952(85)90208-4 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Chemistry Pharmacy, Therapeutics, & Pharmacology |
ExternalDocumentID | 2998400 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -~X .55 .GJ .HR .~1 0R~ 1RT 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 6J9 7-5 8P~ 9JM AABNK AACTN AAEDW AALRI AAOAW AAQFI AAQXK AAXUO ABFNM ABFRF ABJNI ABLJU ABMAC ACGFO ACGFS ACIUM ACNCT ACRLP ADMUD AEFWE AENEX AFFNX AFTJW AGUBO AHHHB AI. AIKHN AITUG ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AZFZN BLXMC CGR CS3 CUY CVF DU5 EBS ECM EIF EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID G-2 G-Q HMT HVGLF HZ~ IH2 J1W K-O L7B M34 N9A NPM O9- OAUVE P2P Q38 R2- ROL SDF SDG SDP SES SPCBC SPT T5K TWZ VH1 WH7 WUQ X7M ZGI ZXP ~G- |
ID | FETCH-LOGICAL-c417t-2b58781b78cb0febaecf631ae8147a88db70af121583c7aa2f4fe630dae975082 |
ISSN | 0006-2952 |
IngestDate | Sat Sep 28 08:37:04 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 23 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c417t-2b58781b78cb0febaecf631ae8147a88db70af121583c7aa2f4fe630dae975082 |
PMID | 2998400 |
ParticipantIDs | pubmed_primary_2998400 |
PublicationCentury | 1900 |
PublicationDate | 1985-12-01 |
PublicationDateYYYYMMDD | 1985-12-01 |
PublicationDate_xml | – month: 12 year: 1985 text: 1985-12-01 day: 01 |
PublicationDecade | 1980 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Biochemical pharmacology |
PublicationTitleAlternate | Biochem Pharmacol |
PublicationYear | 1985 |
SSID | ssj0006861 |
Score | 1.3807371 |
Snippet | African trypanosomes, like Trypanosoma brucei, depend on antigenic variation to evade the immune response of the vertebrate host. An antigenic switch... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 4151 |
SubjectTerms | Animals Antigens, Protozoan Benzamides - blood Benzamides - pharmacology DNA Repair Female Glycoproteins - genetics Guinea Pigs Mice Nucleotidyltransferases - physiology Poly(ADP-ribose) Polymerases Rats Trypanosoma brucei brucei - drug effects Trypanosoma brucei brucei - immunology Variant Surface Glycoproteins, Trypanosoma |
Title | Effect of 3-aminobenzamide on antigenic variation of Trypanosoma brucei |
URI | https://www.ncbi.nlm.nih.gov/pubmed/2998400 |
Volume | 34 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dSxwxEA_aUupLsVpRWyUPrSjn6n7lYx_L4QeFig8n-iZJNoETL3uch6B_vZNNbnc9LFVflpAsIezvt5OZSWYGoZ8GLK5SUhqlSQYGClFFJCUlkYYWESw3ZV2-7e8ZPb3I_1yRq9ahX0eXTOWBenwxruQ9qEIf4OqiZN-AbDMpdEAb8IUnIAzPV2EcUg-DvpdFYjS0ldT2ERql7tWXjKcu1eZQ9e7BIG5Uw8HkASRAdVeNRE86ZIfPDnaHroSWzyEwbtNaN473fjWx-tYd4tsgVhrI6kulPu9_x0NaTUJUSXtOL-yNJ8pl63NICk469zdmchTQLcgzORqckp4vadaRiqAkJC-Ka-85aGYDnZqTX26DTGPug386KI5HNYwwDEZp_N_BuTTaYWQRLTLu5OGZ8-qEHZtyGior-nXMQiwTetj07XKyF9a1hD6F2eZskVonGSyjL8GYwL89M76iBW1X0Of-rIbfCto59xA-7ONBG2h3t4938HkH3FV04qmEK4PnqYQrixsq4YZK7tUOlbCn0jd0cXw06J9GocZGpPKETaNUEs7AdGFcydhoKbQyNEuE5knOBOelZLEwLgUJzxQTIjW50TSLS6ELUDZ5uoY-2MrqdYRFZpSOY5MrMLu1FoIZkbLCFY43gmu5gdb8x7oe-0Qq1-Erbv5r4Dtaatn3A3008N_qLVACp3K7RvAJRBZYQw |
link.rule.ids | 783 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+3-aminobenzamide+on+antigenic+variation+of+Trypanosoma+brucei&rft.jtitle=Biochemical+pharmacology&rft.au=Cornelissen%2C+A+W&rft.au=Michels%2C+P+A&rft.au=Borst%2C+P&rft.au=Spanjer%2C+W&rft.date=1985-12-01&rft.issn=0006-2952&rft.volume=34&rft.issue=23&rft.spage=4151&rft_id=info:doi/10.1016%2F0006-2952%2885%2990208-4&rft_id=info%3Apmid%2F2998400&rft_id=info%3Apmid%2F2998400&rft.externalDocID=2998400 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-2952&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-2952&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-2952&client=summon |